Fig. 3From: Neurodevelopmental trajectories, polygenic risk, and lipometabolism in vulnerability and resilience to schizophreniaEnrichment analyses for genes of SZ-PRS at pT 0.0001. A GO pathway enrichment analyses for genes of SZ-PRS at pT 0.0001. B KEGG pathway enrichment analyses for genes of SZ-PRS at pT 0.0001. AMPK, AMP-activated protein kinaseBack to article page